Medicine and Dentistry
Blood Donor
100%
Severe Acute Respiratory Syndrome Coronavirus 2
72%
Donor
71%
Infection
66%
Prevalence
38%
Antibody
37%
Adverse Event
27%
Female
25%
Hepatitis E Virus
24%
Seroprevalence
21%
Patient
21%
Cohort Analysis
19%
Alertness
18%
Mortality Rate
18%
Virus Infection
18%
RNA
18%
Pneumonia
18%
Blood Group ABO System
18%
Reinfection
18%
Immunocompromised Patient
18%
Hepatitis E
18%
Adult
18%
Blood Group O
18%
Cohort Effect
18%
Nucleic Acid
18%
Lochia
18%
Ferritin
18%
Iron
18%
Bleeding
18%
Signal Transduction
18%
Myometrium
18%
Pregnancy
18%
Supplementation
18%
Progesterone
18%
Migraine
18%
Pericarditis
18%
Placebo
18%
Evaluation Study
18%
Cross Sectional Study
18%
Odds Ratio
16%
Homelessness
15%
Hemoglobin
15%
Male
14%
Follow up
13%
Comprehension
13%
Satisfaction
13%
COVID-19
10%
Polymerase Chain Reaction
10%
Physician
9%
Genetic Correlation
9%
Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
90%
Monospecific Antibody
48%
COVID-19
41%
Hepatitis E Virus
31%
Viral Disease
24%
Hepatitis E
22%
Neutralization
21%
Prevalence
20%
Blood Plasma
19%
Time
18%
Mortality Rate
18%
Antibody Screening
18%
Infliximab
18%
Azathioprine
18%
ABO Blood Group System
18%
Blood Group O
18%
Inflammatory Bowel Disease
18%
Immunocompromised Patient
18%
Neutralizing Antibody
18%
Pharmacokinetics
18%
Pericarditis
18%
Omicron Coronavirus Variant
18%
Seroprevalence
12%
Immunoglobulin M
10%
Antigenicity
6%
Blood Group
5%